169 related articles for article (PubMed ID: 15877808)
1. Heparin-induced thrombocytopenia antibody and the pathogenesis of thrombotic microangiopathy after stem cell transplantation.
Takatsuka H; Nakajima T; Nomura K; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H
Clin Transplant; 2005 Jun; 19(3):418-22. PubMed ID: 15877808
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.
Mattioli AV; Bonetti L; Carletti U; Ambrosio G; Mattioli G
Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851
[TBL] [Abstract][Full Text] [Related]
3. Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis.
Nakamoto H; Shimada Y; Kanno T; Wanaka K; Matsuo T; Suzuki H
Hemodial Int; 2005 Oct; 9 Suppl 1():S2-7. PubMed ID: 16223438
[TBL] [Abstract][Full Text] [Related]
4. Serum antibodies to the heparin/platelet factor 4 complex are an independent predictor of thrombotic complications following pediatric fontan surgery.
Zhang R; Huang Y; Zhang M; Bai J; Liu J
Clin Appl Thromb Hemost; 2012 Sep; 18(5):448-52. PubMed ID: 22679243
[TBL] [Abstract][Full Text] [Related]
5. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
6. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
Matsuo T; Tomaru T; Kario K; Hirokawa T;
Thromb Res; 2005; 115(6):475-81. PubMed ID: 15792678
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
10. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
Yeh RW; Everett BM; Foo SY; Dorer DJ; Laposata M; Van Cott EM; Jang IK
Am J Cardiol; 2006 Aug; 98(3):419-21. PubMed ID: 16860036
[TBL] [Abstract][Full Text] [Related]
11. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
Lo GK; Sigouin CS; Warkentin TE
Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
[TBL] [Abstract][Full Text] [Related]
12. Association of Helicobacter pylori with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome after bone marrow transplantation.
Takatsuka H; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H; Kakishita E
Clin Transplant; 2004 Oct; 18(5):547-51. PubMed ID: 15344958
[TBL] [Abstract][Full Text] [Related]
13. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
Pouplard C; May MA; Regina S; Marchand M; Fusciardi J; Gruel Y
Br J Haematol; 2005 Mar; 128(6):837-41. PubMed ID: 15755289
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia associated with thrombotic microangiopathy.
Studt JD; Binet I; Nair G; Schanz U
Hamostaseologie; 2013 May; 33(2):160-3. PubMed ID: 23715106
[TBL] [Abstract][Full Text] [Related]
15. Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO).
Iacopino P; Pucci G; Arcese W; Bosi A; Falda M; Locatelli F; Marenco P; Miniero R; Morabito F; Rossetti F; Sica S; Uderzo C; Bacigalupo A
Bone Marrow Transplant; 1999 Jul; 24(1):47-51. PubMed ID: 10435734
[TBL] [Abstract][Full Text] [Related]
16. Heparin cofactor II as a predictor of thrombotic microangiopathy after bone marrow transplantation.
Takatsuka H; Nakajima T; Nomura K; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H
Hematology; 2006 Apr; 11(2):101-3. PubMed ID: 16753849
[TBL] [Abstract][Full Text] [Related]
17. Heparin-induced thrombocytopenia after liver transplantation.
Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Makuuchi M
Transplant Proc; 2008 Jun; 40(5):1518-21. PubMed ID: 18589141
[TBL] [Abstract][Full Text] [Related]
18. Management of liver transplantation in a patient with a history of heparin-induced thrombocytopenia.
Fretschner R; Dietrich K; Unertl K; Greinacher A
Transpl Int; 2005 Jun; 18(6):664-7. PubMed ID: 15910290
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of measuring for fragmented red cells using an automated hematology analyzer in patients with thrombotic microangiopathy.
Abe Y; Wada H; Yamada E; Noda M; Ikejiri M; Nishioka J; Kobayashi T; Matsumoto T; Masuya M; Isaji S; Usui M; Uemoto S; Katayama N; Nobori T
Clin Appl Thromb Hemost; 2009; 15(3):257-62. PubMed ID: 18603539
[TBL] [Abstract][Full Text] [Related]
20. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
